- Filed
- Mar 2, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Feb 16, 2021 | 33.14M sh |
| Shares Diluted | FY 2020 · Dec 31, 2019 | 34.28M sh |
| Stock Repurchased | FY 2020 · Dec 31, 2019 | $45.01M |
| Capex restated | FY 2020 · Dec 31, 2019 | $189.04M |
| Operating Cash Flow | FY 2020 · Dec 31, 2019 | $178.73M |
| Short Term Debt restated | FY 2020 · Dec 31, 2019 | $132K |
| Cash And Equivalents | FY 2020 · Dec 31, 2019 | $16.68M |
| Current Liabilities | FY 2020 · Dec 31, 2019 | $326.65M |
| Total Liabilities | FY 2020 · Dec 31, 2019 | $1.01B |
| Current Assets | FY 2020 · Dec 31, 2019 | $435.92M |
| Total Assets | FY 2020 · Dec 31, 2019 | $1.42B |
| Sga Expense restated | FY 2020 · Dec 31, 2019 | $141.73M |
| Net Income | FY 2020 · Dec 31, 2019 | −$102.38M |
| Cost Of Revenue restated | FY 2020 · Dec 31, 2019 | $481.6M |
| Revenue restated | FY 2020 · Dec 31, 2019 | $796.01M |
| Stockholders Equity | FY 2020 · Dec 31, 2018 | $552.82M |